ConductScience.org, home

Paper36819797

Highlights from ecancer Choosing Wisely Nepal 2022: critical appraisal skills for evidence-based practice, 24th-25th September 2022, Kathmandu, Nepal.

Poudyal BS and 3 others. Ecancermedicalscience, 2022. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Highlights from ecancer Choosing Wisely Nepal 2022: critical appraisal skills for evidence-based practice, 24th-25th September 2022, Kathmandu, Nepal. Papers, record 36819797. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36819797

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Highlights from ecancer Choosing Wisely Nepal 2022: critical appraisal skills for evidence-based practice, 24th-25th September 2022, Kathmandu, Nepal.
PubMed
Journal
Ecancermedicalscience
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2023-02-24
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Poudyal BSBishesh Sharma
2Dulal SSoniya
3Shilpakar RRamila
4Gyawali BBishal

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130374970Association between progression-free survival and patients' quality of life in cancer clinical trials.Int J Cancer2019https://conductscience.org/library/papers/30374970PubMed
230528804A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology.Eur J Cancer2019https://conductscience.org/library/papers/30528804PubMed
333555940Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments.J Clin Oncol2021https://conductscience.org/library/papers/33555940PubMed
434325401Do Editorialists With Industry-Related Conflicts of Interest Write Unduly Favorable Editorials for Cancer Drugs in Top Journals?J Natl Compr Canc Netw2021https://conductscience.org/library/papers/34325401PubMed
535985695Ensuring quality in contextualised cancer management guidelines for resource-constraint settings: using a systematic approach.BMJ Glob Health2022https://conductscience.org/library/papers/35985695PubMed
630241238What Global Oncology Needs: Mutual Learning and More Funding.J Glob Oncol2018https://conductscience.org/library/papers/30241238PubMed
733412270Have investigators forgotten how to write?Ann Oncol2021https://conductscience.org/library/papers/33412270PubMed
830385466Reporting harms more transparently in trials of cancer drugs.BMJ2018https://conductscience.org/library/papers/30385466PubMed
929508746Cancer groundshot: going global before going to the moon.Lancet Oncol2018https://conductscience.org/library/papers/29508746PubMed
1016740527The great medicines scandal.BMJ2006https://conductscience.org/library/papers/16740527PubMed
1135440715Cancer treatments should benefit patients: a common-sense revolution in oncology.Nat Med2022https://conductscience.org/library/papers/35440715PubMed
1227353411Use of donated clotting factors for surgeries on haemophilic patients in a resource-constrained country: a kind donor, good outcome, change of practice and future directions.Haemophilia2016https://conductscience.org/library/papers/27353411PubMed
1332735488Overview of Delivery of Cancer Care in Nepal: Current Status and Future Priorities.JCO Glob Oncol2020https://conductscience.org/library/papers/32735488PubMed
1433216359The need for locally generated data in haematology: a real-world experience of aplastic anaemia in Nepal.Br J Haematol2021https://conductscience.org/library/papers/33216359PubMed
1535242221Clinical research in oncology: in memory of Professor Gordon McVie.Ecancermedicalscience2022https://conductscience.org/library/papers/35242221PubMed
1632298471Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking Value.Clin Pharmacol Ther2020https://conductscience.org/library/papers/32298471PubMed
1733507236An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.JAMA Oncol2021https://conductscience.org/library/papers/33507236PubMed
1836273670Rules for the conduct of clinical trials need revision, but 'good clinical practice' requires much more.Ann Oncol2023https://conductscience.org/library/papers/36273670PubMed
1915143092Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting.J Clin Oncol2004https://conductscience.org/library/papers/15143092PubMed
2035182794Hematopoietic Stem Cell Transplantation in Nepal: International Partnership, Implementation Steps, and Clinical Outcomes.Transplant Cell Ther2022https://conductscience.org/library/papers/35182794PubMed

See all 28 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36819797

GET https://conductscience.org/api/papers/v1/36819797/references?page=2